KMT2D is frequently mutated in DLBCL (~ 30% of de novo cases, including both germinal center B-cell and activated B-cell subtypes and follicular lymphoma (~ 90%)) [23]. The gene discussed is KMT2D; the disease is follicular lymphoma.